Published in Exp Aging Res on June 06, 2000
Kinematic measures for assessing gait stability in elderly individuals: a systematic review. J R Soc Interface (2011) 1.52
Gait unsteadiness and fall risk in two affective disorders: a preliminary study. BMC Psychiatry (2004) 1.14
Early onset of stabilizing strategies for gait and obstacles: older adults with Down syndrome. Gait Posture (2008) 1.01
Linear and angular control of circular walking in healthy older adults and subjects with cerebellar ataxia. Exp Brain Res (2012) 0.77
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet (1998) 1.84
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurology (2001) 1.71
Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 1.68
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol (2000) 1.40
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology (2005) 1.34
Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology (2001) 1.25
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology (2004) 1.15
Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection (1991) 1.12
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol (2005) 1.09
Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet (2001) 1.08
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism Relat Disord (1997) 1.06
[Diagnosis encoding: how and to what purpose?]. Dtsch Med Wochenschr (1986) 1.04
Exclusion of chromosome regions 6p12 and 15q11, but not chromosome region 7p11, in a German family with autosomal dominant congenital nystagmus. Genomics (1998) 1.04
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord (2005) 1.01
Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol (1994) 1.00
Role of mitochondria in Parkinson disease. Biol Chem (1999) 0.98
Personality traits in young patients with Parkinson's disease. Acta Neurol Scand (2001) 0.97
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96
Goitre epidemiology: thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) (1986) 0.95
Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 0.94
The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet (2001) 0.93
Nonrandomized comparison of open flank versus laparoscopic nephrectomy in 249 patients with benign renal disease. Eur Urol (2001) 0.93
Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial. Pediatrics (1998) 0.93
Refinement of the spinocerebellar ataxia type 4 locus in a large German family and exclusion of CAG repeat expansions in this region. J Neurol (2003) 0.91
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology (2005) 0.90
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology (2003) 0.90
Focal and segmental primary dystonia in north-western Germany--a clinico-genetic study. Acta Neurol Scand (2003) 0.89
Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test (1999) 0.89
Sexuality in young patients with Parkinson's disease: a population based comparison with healthy controls. J Neurol Neurosurg Psychiatry (2000) 0.88
Attitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing. Genet Couns (2001) 0.88
Parkinsonism in multiple sclerosis. Mov Disord (1992) 0.87
Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's disease. J Neuroimmunol (1999) 0.86
Neurology of adult alpha-mannosidosis. J Neurol Neurosurg Psychiatry (1996) 0.85
Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma. J Neurol Neurosurg Psychiatry (1994) 0.85
Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann Neurol (2000) 0.84
Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm (Vienna) (2003) 0.84
A study of visual hallucinations in patients with Parkinson's disease. J Neurol (1997) 0.83
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology (2006) 0.83
Smoking and Parkinson's disease: a case-control study in Germany. Int J Epidemiol (1997) 0.82
On the reasons for the delay of P3 latency in healthy elderly subjects. Electroencephalogr Clin Neurophysiol (1991) 0.82
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology (2000) 0.81
[Gait disturbances in neurology]. Nervenarzt (2008) 0.81
Familial glioma: occurrence within the "familial cancer syndrome" and systemic malformations. J Neurol (1987) 0.81
Ischemic stroke due to transient thrombosis of the internal carotid artery in a patient with combined antiphospholipid syndrome and factor V Leiden. Am J Med (1999) 0.80
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.80
Fahr's disease--far from a disease. Mov Disord (1998) 0.80
Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease. J Neurol Sci (1995) 0.80
Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 0.80
Semen parameters in men with and without proven chronic prostatitis. Arch Androl (1991) 0.80
[Hirayama disease in Germany: case reports and review of the literature]. Nervenarzt (2011) 0.80
Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. J Neural Transm (Vienna) (1996) 0.80
[Endoscopic use of the water jet dissector in the cerebral ventricle system--an experimental study]. Zentralbl Neurochir (2000) 0.80
Thalamic stroke: correlation of clinical symptoms, somatosensory evoked potentials, and CT findings. Acta Neurol Scand (1994) 0.79
Voluntary palatal tremor in two siblings. Mov Disord (1998) 0.79
[Multifactorial etiology of idiopathic Parkinson disease. A case-control study]. Nervenarzt (1994) 0.79
The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies. Adv Neurol (1999) 0.79
Ureaplasmal infections of the male urogenital tract, in particular prostatitis, and semen quality. Urol Int (1985) 0.79
Parkinson disease: analysis of mitochondrial DNA in monozygotic twins. Neurogenetics (2000) 0.78
Coincidence of multiple sclerosis and glioma. Clinical and radiological remarks on two cases. Surg Neurol (1986) 0.78
[Initial therapy of acute unilateral epididymitis using ofloxacin. I. Clinical and microbiological findings]. Urologe A (1990) 0.78
Responses to cued signals in Parkinson's disease. Distinguishing between disorders of cognition and of activation. Brain (1997) 0.78
[Congenital protein C deficiency and thromboembolic diseases]. Dtsch Med Wochenschr (1987) 0.78
Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET study. Neurology (2002) 0.78
Increased risk of Parkinson's disease in relatives of patients. Ann Neurol (1995) 0.78
Parkinson's disease in twins. Neurology (1992) 0.78
Defective production of interleukin-2 in patients with idiopathic Parkinson's disease. J Neurol Sci (1995) 0.78
The parkin gene is not involved in late-onset Parkinson's disease. Neurology (2002) 0.78
Balloon kyphoplasty improves back pain but does not result in a permanent realignment of the thoracolumbar spine. Cent Eur Neurosurg (2011) 0.77
Gelastic epilepsy: Sturge-Weber syndrome with seizure facilitation. Schweiz Arch Neurol Psychiatr (1995) 0.77
Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis. Acta Neuropathol (2001) 0.77
Peripheral myoclonus due to spinal root lesion. Muscle Nerve (1997) 0.77
Movement-related cortical potentials preceding sequential and goal-directed finger and arm movements in patients with cerebellar atrophy. Electroencephalogr Clin Neurophysiol (1994) 0.77
Value of acute-phase proteins in the differential diagnosis of acute scrotum. Eur Urol (2001) 0.77
The relevance of clinical subtypes for disease course, family history and epidemiological variables in Parkinson's disease. Eur J Neurol (1994) 0.77
Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: further clinical evidence. J Neural Transm (Vienna) (1999) 0.77
Mathematic modeling to predict abruptio placentae. Am J Obstet Gynecol (2000) 0.77
Search for a founder mutation in idiopathic focal dystonia from Northern Germany. Am J Hum Genet (1998) 0.77
[Lymph node metastasis in head-neck tumors]. Laryngorhinootologie (2001) 0.77
The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry (1996) 0.76
Voluntary palatal tremor is associated with hyperactivation of the inferior olive: a functional magnetic resonance imaging study. Mov Disord (2001) 0.76
Ultrastructural and ultrahistochemical investigations of lead-induced intranuclear inclusion bodies in rat kidney. Exp Pathol (1983) 0.76
Cerebral venous thrombosis in hereditary protein C deficiency. J Neurol Neurosurg Psychiatry (1989) 0.76
Amyotrophic lateral sclerosis and frontal lobe dementia in Alzheimer's disease. Case report and review of the literature. Eur Neurol (1993) 0.76
Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes. Exp Clin Endocrinol (1994) 0.76
Multiple sclerosis and cerebral tumor. Clin Neuropathol (1984) 0.76
Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial. Thromb Haemost (1995) 0.76
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. Neurology (1998) 0.76
The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases. Neurosci Lett (1999) 0.76
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol (1996) 0.76
Tetrabenazine in the treatment of senile vocal tics. J Neurol (1987) 0.76
Time of drug elimination in chronic drug abusers. Case study of 52 patients in a "low-step" detoxification ward. Forensic Sci Int (2001) 0.76
Workshop IV: drug treatment guidelines for the long-term management of Parkinson's disease. J Neurol (2000) 0.76
Central pain as a manifestation of partial epileptic seizures. Pain (1999) 0.75